Altitude Ventures

Altitude Ventures (AV) is a Nashville-based venture capital firm that has quietly become one of the Southeast's most active early-stage healthcare investors. Since founding in 2012, the firm has built a focused practice around healthcare services and digital health companies, deploying capital from seed through Series B with initial check sizes ranging from $1 million to $10 million.

Unlike broad-based VCs that spread across sectors, Altitude Ventures concentrates exclusively on healthcare—a deliberate strategy that allows the team to develop deep domain expertise and a network of relationships across hospital systems, payer organizations, and healthcare operators throughout the region. Nashville's concentration of healthcare Fortune 500 companies (HCA, Change Healthcare, HealthStream) creates a talent pipeline and deal flow that AV has capitalized on.

This guide covers everything you need to know about Altitude Ventures: their specific investment thesis, real portfolio companies, typical check sizes and deal terms, and practical advice for getting a meeting. Whether you're building a healthcare SaaS platform, a digital health app, or a tech-enabled service business, understanding AV's specific preferences will dramatically improve your fundraising odds.

Altitude Ventures invests in healthcare services and digital health companies that improve the efficiency, quality, or accessibility of healthcare delivery. The firm's thesis centers on a simple conviction: the U.S. healthcare system is undergoing a structural shift from volume-based to value-based care, and companies that help providers, payers, and patients navigate this transition will be the winners.

Within healthcare, AV focuses on several specific verticals: clinical workflow optimization, revenue cycle management, telehealth and remote patient monitoring, healthcare workforce solutions, and tech-enabled services that reduce administrative burden. The firm explicitly avoids biotech, medical devices with hardware components, and companies that require lengthy FDA approval processes—this is a software and services thesis.

The Nashville location is strategic, not incidental. The city is home to HCA Healthcare (one of the largest hospital operators in the U.S.), Change Healthcare, Acadia Healthcare, and HealthStream—all companies that have generated a deep pool of healthcare technology talent. AV leverages this ecosystem to source deals and provide portfolio companies with customer introductions that would be difficult to access from San Francisco or New York.

What distinguishes AV from other early-stage healthcare VCs is their operational focus. The team has backgrounds in healthcare operations, not just finance. This means they ask different questions in due diligence—less about the fintech model and more about how a product actually integrates into clinical workflows, how it gets sold to procurement, and what drives adoption among busy clinicians.

AV looks for companies addressing large, growing markets with demonstrated early traction. The firm prefers businesses that have already proven some degree of product-market fit before seeking Series A funding, even at the seed stage. This means showing recurring revenue metrics, strong customer retention, or meaningful usage metrics that indicate the product solves a real problem.

The firm's investment philosophy is fundamentally a partnership model. AV expects to be deeply involved with portfolio companies—taking board seats, making customer introductions, and providing strategic guidance on hiring and operations. They are not passive investors and expect founders to want that level of engagement.

Altitude Ventures has maintained an active investment pace through 2024 and 2025, participating in 16 documented investments across the healthcare technology landscape. The firm's most recent funds have supported companies at the intersection of AI and healthcare operations, reflecting the broader trend toward automation in clinical and administrative workflows.

Notable recent activity includes leading or co-leading rounds for companies in the $3M–$8M range, with AV's initial tickets typically between $1M and $5M. The firm has demonstrated willingness to increase position sizes in follow-on rounds for portfolio companies that hit milestones, with reserves set aside specifically for acceleration rounds.

AV's deal flow benefits from the Nashville healthcare ecosystem's concentration. With major health systems, healthcare technology companies, and health insurance operations headquartered within a 20-mile radius, deal sourcing happens through a combination of inbound outreach, warm introductions from the healthcare executive community, and participation in local events like the Nashville Health Care Council's programming.

The firm has shown particular interest in companies addressing healthcare workforce challenges—staffing optimization, clinician scheduling, and administrative burden reduction—as these issues have intensified since the pandemic and show no signs of abating. Healthcare staffing shortages have created a secular tailwind for solutions that help providers do more with less.

In addition to new investments, AV has been active in supporting existing portfolio companies through growth stages. This includes leading or participating in Series A and Series B extensions for companies that are scaling their customer base and expanding their go-to-market capabilities.

Altitude Ventures's portfolio reflects the firm's thesis: healthcare services and digital health companies that reduce costs, improve quality, or increase accessibility of care. The portfolio spans early-stage companies that have raisedSeed and Series A rounds to more mature businesses approaching Series B.

DocYT is one of AV's most prominent portfolio companies—a healthcare AI platform focused on clinical documentation and ambient intelligence for physicians. The company addresses one of the most significant pain points in healthcare: the administrative burden that consumes physician time and contributes to burnout. DocYT uses large language models to automate documentation, allowing clinicians to focus on patient care rather than charting.

Spry Physicians is another notable holding—a digital health platform connecting independent physician practices with group purchasing organizations, managed care contracts, and operational resources. The platform addresses the fragmentation of independent medicine by providing smaller practices with the same negotiating power and operational support that large health systems enjoy.

The portfolio also includes several companies addressing behavioral health access—a strategic focus given Nashville's strong position in this space through companies like Acadia Healthcare. AV has backed platforms that connect patients with behavioral health services, simplify referral workflows for primary care providers, and support health systems in building integrated behavioral health programs.

Other portfolio companies span revenue cycle management, healthcare data interoperability, telehealth platforms, and clinical decision support tools. The common thread across all holdings is operational involvement in the healthcare system—companies that are not just software tools but are embedded in clinical and administrative workflows.

Portfolio companies benefit from AV's network in ways that go beyond capital. The firm's relationships with Nashville's healthcare executives create partnership and customer opportunities that early-stage companies outside the region simply cannot access. This is particularly valuable for companies trying to land pilot programs with major health systems, which remain the dominant customers in the healthcare technology market.

Altitude Ventures evaluates potential investments based on several criteria that reflect the firm's operational focus and healthcare domain expertise. Understanding these specifics will help you determine whether AV is the right investor for your company and how to position your pitch.

The founding team is the single most important factor in AV's investment decisions. The firm looks for founders with direct experience in the healthcare sector—whether as operators, clinicians, or healthcare technologists. Founders who have lived the problem they are solving bring credibility and domain knowledge that generalist investors cannot replicate. AV is skeptical of founders who have healthcare ambition but no healthcare background.

Market size and growth trajectory matter, but AV is not chasing the largest possible TAM. The firm prefers companies addressing specific, well-defined problems within healthcare that can achieve meaningful revenue ($50M+ ARR benchmarks) without needing to displace incumbent systems entirely. Healthcare's complexity and fragmentation create niche opportunities that AV has historically favored over broad horizontal plays.

Business model clarity is essential. AV strongly prefers companies with recurring revenue metrics—SaaS subscriptions, per-member-per-month arrangements, or value-based contracts—over transaction-based or service-based models. The firm believes that software-defined businesses with strong unit economics create more durable value than services businesses that scale through headcount.

Traction metrics that matter to AV go beyond vanity metrics. The firm wants to see customer retention data, net revenue retention for companies with existing customers, clinical outcome data for companies addressing quality measures, and evidence of product-market fit in specific healthcare verticals. Healthcare sales cycles are long, so early traction needs to be significant enough to demonstrate genuine demand, not just initial interest.

Competitive positioning is carefully evaluated. AV looks for companies with meaningful moats—whether proprietary data assets, embedded integrations with major EHR systems, exclusive contracts with health systems, or regulatory advantages that create barriers to entry. In healthcare, these moats are often more durable than technology advantages alone.

Path to scale is evaluated with a realistic eye toward the challenges of healthcare go-to-market. AV understands that selling to health systems requires navigating procurement processes, security reviews, and implementation cycles that can extend to 12-18 months. The firm looks for founders who understand this reality and have strategies for navigating it.

Getting a meeting with Altitude Ventures requires a strategic approach that reflects the firm's focused investment thesis and the healthcare ecosystem's relationship-driven dynamics. A poorly targeted cold outreach will not get a response—AV receives thousands of pitch decks each year and can afford to be selective.

Warm introductions remain the highest-value path into AV. The firm is significantly more likely to meet with founders who come through trusted referrals from healthcare executives, angel investors who have backed successful healthcare companies, or fellow VCs in the regional ecosystem. If you have relationships with Nashville healthcare operators or investors, leverage them. Intro emails from trusted sources dramatically increase response rates.

For founders without existing regional relationships, the cold outreach path is viable but requires precision. Your deck needs to immediately signal that you understand AV's specific focus—healthcare services and digital health—and that you are not a generalist startup looking for any interested VC. Lead with your healthcare domain expertise and specific traction in the healthcare vertical.

When preparing your outreach, focus on the problem you are solving and the evidence you have that healthcare organizations will pay for the solution. AV will not engage with companies that are pre-revenue with purely theoretical market opportunities. Show that you have real customers, real retention, and a credible path to scaling within the healthcare system.

If you are able to secure a meeting, come prepared for a substantive technical discussion. AV's team will ask detailed questions about your product, your customers, your metrics, and your understanding of the competitive landscape. The firm is known for being direct and thorough in diligence—the goal is to understand whether you truly understand the healthcare market you are entering.

Follow-up discipline matters. AV typically takes 3-6 weeks to move from first meeting to investment decision, and the process includes multiple conversations and reference checks. Stay in communication without being pushy—send brief updates on milestones, new customer signings, or significant operational developments that reinforce your thesis.

Even if AV does not invest in your current round, maintain the relationship. The firm is influential in the Nashville healthcare ecosystem and can provide introductions to other investors, potential customers, or industry experts who can help your company grow. AV has a long-term orientation and values founders who approach the relationship as a partnership, not a transaction.

Altitude Ventures invests in early-stage companies, but they expect founders to have a sophisticated handle on their financials. Healthcare companies have unique economic characteristics—long sales cycles, complex contract structures, recurring revenue metrics models—that require careful financial modeling and clear communication of unit economics.

Founders who walk into AV meetings without a coherent financial model signal inexperience. Investors in this space need to see that you understand your customer acquisition costs, your revenue recognition structure, your path to profitability, and your cash flow management dynamics. Healthcare SaaS businesses often have multi-year contracts with staggered billing that requires nuanced financial presentation.

Working with a fractional CFO who understands healthcare business models can significantly improve your fundraising positioning. Healthcare investors expect financial projections that reflect the reality of enterprise sales cycles, implementation timelines, and the regulatory environment. A CFO who has walked entrepreneurs through healthcare fundraising before will help you avoid common pitfalls.

Your financial model should reflect realistic growth trajectories that account for healthcare's slower but stickier enterprise adoption. AV will challenge overly optimistic projections—healthcare technology companies that show 200% year-over-year growth are rare. More realistic expectations are 50-80% annual growth with high customer retention.

Key metrics for healthcare SaaS companies include gross margin, net revenue retention, customer lifetime value, and the ratio of LTV to CAC. These metrics demonstrate the fundamental health of your business model and show AV that you understand the economics of the market you are operating in.

Whether you are preparing to pitch Altitude Ventures or other healthcare-focused VCs, having professional financials and a clear strategic narrative will set you apart from founders who come with vague projections and underdeveloped business models. Our team has helped numerous healthcare technology companies raise capital and understand exactly what investors like AV are looking for in financial presentations.

Looking for other healthcare-focused investors? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors, including other Nashville-based and Southeast-focused healthcare VCs.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding from specific firms. Whether you are building a digital health platform, a healthcare SaaS tool, or a tech-enabled service business, you will find relevant insights in our VC firm guides.

The Southeast has become an increasingly important region for healthcare innovation, with Nashville serving as the hub. Understanding the local investor landscape and building relationships with regional VCs can dramatically improve your fundraising outcomes compared to pursuing only coastal investors.